Genetic Testing and Gene Therapy Notes

  • Genetic Testing

    • Definition: Genetic testing is the analysis of chromosomes, DNA, RNA, and proteins to detect abnormalities that can lead to genetic diseases.

    Population Screening

    • Definition and Importance:

      • Population screening involves large-scale testing to identify individuals who may have a disease or are at risk of having one.

      • Example: Newborn screening for diseases such as Phenylketonuria (PKU).

    • PKU Screening:

      • Occurs in newborns with incidence rates between 1 in 10,0001 \text{ in } 10,000 to 1 in 15,0001 \text{ in } 15,000 in whites in the U.S.

      • Early identification through dietary intervention can prevent cognitive impairment.

    • Types:

      • Newborn Screening: Early tests for genetic conditions.

      • Family Screening: Testing family members when a condition is known to run in families.

    Principles of Screening

    • There are six key principles for effective screening:

      1. Serious and Relatively Common Condition: The condition being screened for should have significant health consequences and occur frequently enough to warrant screening.

      2. Clear Understanding of Natural History: The progression and implications of the disease must be well-understood to ensure effective screenings.

      3. Acceptable and Effective Treatments Available: There must be viable options for treatment or management following a positive screening.

      4. Ease of Testing: Screening should be straightforward, inexpensive, and minimally invasive.

      5. Valid and Reliable Tests: Tests must provide accurate results in identifying those with and without the disease.

      6. Accessible Resources for Diagnosis and Treatment: Necessary resources must be available for assessing and treating positive cases.

    Validity of Tests

    • Definitions:

      • Validity: Reflects how well a test identifies those who have the disease (sensitivity) versus those who do not (specificity).

      • Sensitivity: Measures the test's ability to correctly identify individuals with the disease (true positives).

      • Specificity: Measures the test's ability to correctly identify individuals without the disease (true negatives).

    • False Positives and False Negatives:

      • High sensitivity may lead to more false positives. For example, in PKU screening, the test can yield a 100%100\% sensitivity, but with many individuals testing positive who do not actually have PKU.

    Predictive Values and Rates

    • Positive Predictive Value (PPV): Proportion of individuals with positive test results who actually have the disease.

      • Calculation: PPV=True PositivesTrue Positives+False Positives\text{PPV} = \frac{\text{True Positives}}{\text{True Positives} + \text{False Positives}}

    • Negative Predictive Value (NPV): Proportion of negative test results that are true negatives.

      • Calculation: NPV=True NegativesTrue Negatives+False Negatives\text{NPV} = \frac{\text{True Negatives}}{\text{True Negatives} + \text{False Negatives}}

    • False Positive Rate: Calculated as 11 minus specificity.

    Case Study: Congenital Adrenal Hyperplasia (CAH)

    • Definitions: CAH is characterized by errors in steroid biosynthesis, and its incidence varies by population (e.g., 1 in 10,0001 \text{ in } 10,000 in whites vs. 1 in 4001 \text{ in } 400 in Yupik population).

    Screening Examples

    • The importance of screening exemplified by the screening for sickle cell disease, which has a significant mortality rate if untreated.

    • Muscular Dystrophy: Screening also provides crucial genetic counseling for reproductive decisions, especially for x-linked conditions.

    Genetic Counseling and Ethical Considerations

    • Role of Genetic Counseling: Important for individuals identified as carriers of genetic conditions to understand implications for family planning.

    • Public Perceptions of Genetic Testing: Mixed reactions regarding testing; concerns about privacy and potential discrimination still persist.

    Prenatal Diagnosis of Genetic Disorders

    • Prenatal tests help identify genetic disorders before birth:

      • Serum Testing (e.g., maternal serum alpha-fetoprotein): Identifies abnormalities via blood tests.

      • Invasive Procedures:

      • Amniocentesis: Needle extraction of amniotic fluid for cell culture, typically done between 15−1715-17 weeks gestation.

      • Chorionic Villus Sampling (CVS): Earlier detection using fetal trophoblastic tissue sampling, performed at about 10−1110-11 weeks.

    • Benefits and risks of procedures such as fetal tissue sampling and the implications of procedures on fetal health, including a 1%1\% risk of fetal death in CVS compared to 0.2−0.3%0.2-0.3\% in amniocentesis.

    Psychological Impacts of Genetic Testing

    • Screening can lead to psychological distress due to the implications of knowing carrier status for conditions such as Huntington's disease, where no treatment exists.

    • Discussions around limitations of genetic testing, including costs, and ethical responses to findings.

    • Direct-to-Consumer Testing: Concerns over misinterpretation of genetic data by consumers, emphasizing the need for qualified counseling.

    Closing Thoughts on Gene Therapy

    • The chapter concludes with a mention of the upcoming discussion on gene therapy, emphasizing the need to review definitions and concepts in this area additional complexity.